Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of "Hold" from Analysts

Key Points

• Analyst consensus is “Hold”: Of 15 brokerages, eight rate Henry Schein a buy, six a hold and one a sell. The average 1-year price target is $92.27.
• Quarterly results exceeded expectations: The company reported EPS of $1.27 versus the $1.24 consensus and revenue of $3.46 billion, up 6.7% year over year and above estimates.
• Shares are trading near their 12-month high: Henry Schein opened at $88.13, compared with a 52-week range of $61.94 to $92.18. Institutional investors own 96.62% of the stock, while an insider recently purchased 10,000 shares.

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has earned an average rating of "Hold" from the fifteen brokerages that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have assigned a buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $92.2667.

A number of equities analysts recently weighed in on the stock. Robert W. Baird set a $97.00 price target on shares of Henry Schein in a report on Wednesday, May 6th. Weiss Ratings restated a "hold (c+)" rating on shares of Henry Schein in a report on Friday, July 31st. Stifel Nicolaus set a $95.00 price objective on shares of Henry Schein in a research report on Wednesday. Morgan Stanley reiterated an "underweight" rating and issued a $64.00 target price (up from $61.00) on shares of Henry Schein in a research note on Friday, April 24th. Finally, Citigroup reissued a "buy" rating and set a $112.00 target price (up from $100.00) on shares of Henry Schein in a research report on Wednesday.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $88.13 on Friday. The business's fifty day simple moving average is $83.49 and its 200 day simple moving average is $78.67. The company has a current ratio of 1.32, a quick ratio of 0.75 and a debt-to-equity ratio of 0.60. Henry Schein has a 12 month low of $61.94 and a 12 month high of $92.18. The firm has a market capitalization of $9.82 billion, a P/E ratio of 25.69, a price-to-earnings-growth ratio of 1.68 and a beta of 0.80.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.03. Henry Schein had a return on equity of 15.97% and a net margin of 2.96%.The firm had revenue of $3.46 billion during the quarter, compared to the consensus estimate of $3.37 billion. During the same quarter in the prior year, the company earned $1.10 EPS. The business's revenue for the quarter was up 6.7% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. As a group, analysts anticipate that Henry Schein will post 5.35 EPS for the current year.

Insider Buying and Selling

In other news, Director William K. Daniel acquired 10,000 shares of the company's stock in a transaction that occurred on Monday, May 11th. The shares were acquired at an average price of $69.19 per share, for a total transaction of $691,900.00. Following the completion of the purchase, the director owned 20,000 shares in the company, valued at approximately $1,383,800. This trade represents a 100.00% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.89% of the company's stock.

Institutional Trading of Henry Schein

Hedge funds have recently made changes to their positions in the company. CYBER HORNET ETFs LLC bought a new position in shares of Henry Schein during the 2nd quarter worth $25,000. MUFG Securities EMEA plc purchased a new stake in Henry Schein in the 2nd quarter worth about $27,000. Flagship Harbor Advisors LLC bought a new stake in Henry Schein in the 4th quarter valued at about $30,000. Federated Hermes Inc. bought a new stake in Henry Schein in the 4th quarter valued at about $32,000. Finally, Los Angeles Capital Management LLC purchased a new stake in Henry Schein during the fourth quarter valued at about $37,000. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source